Cargando…
Evaluation of a thrice weekly administration of teicoplanin in the outpatient setting: a retrospective observational multicentre study
INTRODUCTION: The glycopeptide teicoplanin is commonly utilized to facilitate outpatient parenteral antimicrobial therapy (OPAT). Licensed for once daily maintenance dosing, teicoplanin’s long half-life allows for less frequent dosing (e.g. thrice weekly) following successful loading. This service e...
Autores principales: | Asumang, John, Heard, Katie L, Troise, Oliver, Fahmy, Sandra, Mughal, Nabeela, Moore, Luke S P, Hughes, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210249/ https://www.ncbi.nlm.nih.gov/pubmed/34223089 http://dx.doi.org/10.1093/jacamr/dlab012 |
Ejemplares similares
-
Once-daily tigecycline for outpatient parenteral antibiotic therapy: a single-centre observational study
por: Hughes, Stephen, et al.
Publicado: (2019) -
COVID-19 and fungal superinfection
por: Heard, Katie L, et al.
Publicado: (2020) -
Optimization of antimicrobial dosing in patients with acute kidney injury: a single-centre observational study
por: Hughes, Stephen, et al.
Publicado: (2022) -
Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series
por: Namkoong, Ho, et al.
Publicado: (2016) -
Evaluating the impact of the ICNET® clinical decision support system for antimicrobial stewardship
por: Heard, Katie L., et al.
Publicado: (2019)